Provided by Tiger Trade Technology Pte. Ltd.

MSA Safety

165.26
-2.4300-1.45%
Post-market: 165.260.00000.00%16:34 EDT
Volume:205.16K
Turnover:33.97M
Market Cap:6.41B
PE:23.27
High:167.03
Open:167.00
Low:164.67
Close:167.69
52wk High:208.92
52wk Low:127.86
Shares:38.77M
Float Shares:36.68M
Volume Ratio:0.86
T/O Rate:0.56%
Dividend:2.10
Dividend Rate:1.27%
EPS(TTM):7.10
EPS(LYR):7.09
ROE:22.22%
ROA:11.09%
PB:4.70
PE(LYR):23.31

Loading ...

ProMIS Neurosciences Announces New Peer-Reviewed Publication Showing Plasma pTau as a Predictive Early Endpoint in Alzheimer’s trials, Supporting its Ongoing Phase 1b PRECISE-AD trial with PMN310

GlobeNewswire
·
Dec 01, 2025

ProMIS Neurosciences to Participate in the 8th Annual Evercore Healthcare Conference

GlobeNewswire
·
Dec 01, 2025

MSA Safety Inc. Chief Accounting Officer Jonathan D. Buck Reports Sale of Common Shares

Reuters
·
Nov 26, 2025

ProMIS Neurosciences Announces Reverse Stock Split

GlobeNewswire
·
Nov 24, 2025

MSA Safety (MSA): Is the Current Valuation an Opportunity After Recent Share Price Dip?

Simply Wall St.
·
Nov 20, 2025

Algorhythm Holdings Reports Record 1,273% Year-Over-Year Revenue Growth in its Third Quarter 2025 Financial Results

GlobeNewswire
·
Nov 19, 2025

Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference

GlobeNewswire
·
Nov 12, 2025

ProMIS Neurosciences Announces Third Quarter 2025 Financial Results & Corporate Highlights

GlobeNewswire
·
Nov 12, 2025

MSA Safety (MSA): Evaluating Valuation as New Certified Safety Products Launch

Simply Wall St.
·
Nov 12, 2025

Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System

GlobeNewswire
·
Nov 10, 2025

Alterity Therapeutics Reports Promising ATH434 Results in MSA Treatment

TIPRANKS
·
Nov 10, 2025

Mineros SA (MSA) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Nov 07, 2025

MSA Safety Inc. Set to Join Baird Global Industrial Conference

Reuters
·
Nov 06, 2025

MSA Safety’s G1 XR SCBA Approval Sparks Buy Rating Amid Optimistic Revenue Outlook

TIPRANKS
·
Nov 05, 2025

MSA Safety Inc. Showcases Latest Detection Solutions at A+A International Trade Fair

Reuters
·
Nov 04, 2025

ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

GlobeNewswire
·
Nov 04, 2025

MSA Safety (MSA) Gets a Buy from D.A. Davidson

TIPRANKS
·
Nov 04, 2025

MSA Safety Keeps Quarterly Dividend at $0.53 per Share, Payable Dec. 10 to Shareholders of Record on Nov. 14

MT Newswires Live
·
Oct 31, 2025

Press Release: MSA Safety Declares Quarterly Dividend

Dow Jones
·
Oct 31, 2025

Alterity Therapeutics Advances MSA Treatment with Promising ATH434 Trial Results

TIPRANKS
·
Oct 31, 2025